Blanket Purchase Agreement 36C24826A0022
- Not listed
- This Blanket Purchase Agreement (BPA) awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 to Abbott Laboratories Inc. is for the provision of blood glucose monitoring supplies, including testing equipment, consumables, and related services, to support veteran healthcare operations. The BPA, valued at up to $3,423,753.75, provides a streamlined procurement mechanism for the VA to efficiently acquire these critical medical products and services through Abbott's...
- The Blanket Purchase Agreement (BPA) awarded by the Veterans Integrated Service Network 10 (VISN 10), a civilian agency, to Abbott Laboratories Inc. for $267,700.00 covers the procurement of Freestyle blood glucose test strips, liquid quality control solutions, and meter maintenance and support coverage. The single-award IDV has an ultimate completion date of July 31, 2026. The first task order issued under this BPA, with a $53,554.00 ceiling value, is for a one-year ordering period beginning...
- The Department of Veterans Affairs (VA) awarded a Blanket Purchase Agreement (BPA) to Abbott Laboratories Inc., a global healthcare company, for the lease of glucometers and the supply of related reagents. The contract, which is associated with the VA's In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) Schedule, has a total ceiling value of $5,203,981.50 and a period of performance through September 30, 2026. As the prime contractor, Abbott Laboratories Inc. will provide the VA's Veterans...
- Abbott Laboratories Inc., through its Abbott Point of Care division, holds a single-award Blanket Purchase Agreement with Veterans Integrated Service Network 6 (VISN 6) valued at $2,624,427.62, awarded on October 31, 2023, with an ultimate completion date of October 30, 2028. The contract was awarded without set-aside designation through full and open competition and operates under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) Master Schedule. Performance...
- Veterans Integrated Service Network 22 established a Blanket Purchase Agreement with Abbott Laboratories Inc. on January 6, 2025, with a ceiling of $5 million and an ultimate completion date of February 9, 2027. The BPA procures i-STAT point-of-care testing devices, analyzers, cartridges, reagents, and associated diagnostic equipment and services for the VA San Diego Healthcare System. Performance occurs at Abbott's North Chicago, Illinois location. The solicitation, posted December 11, 2024,...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA) to Abbott Laboratories Inc., a global healthcare company and manufacturer of medical devices, diagnostic equipment, pharmaceuticals, and clinical testing technologies. The contract, valued at a ceiling of $1,652,770.00, is for the delivery of i-STAT point-of-care handheld blood analyzers and associated reagents. The BPA, which does not have a set-aside designation, will be used by the VA's...
- Veterans Integrated Service Network 16 awarded a Blanket Purchase Agreement to Abbott Laboratories Inc. on May 1, 2024, with a $4,575,503.08 ceiling and performance through April 30, 2029, against the GSA In-Vitro Diagnostics, Reagents, Test (FSS-65-VII) Schedule for cost-per-test point-of-care testing equipment, reagents, and supplies supporting VISN 16 medical centers. Performance is based in North Chicago, Illinois. The BPA operates on a firm fixed-price, cost-per-test pricing model with no...
- Veterans Integrated Service Network 22 awarded a Blanket Purchase Agreement to Abbott Laboratories Inc. on September 30, 2024, with a ceiling of $1,319,397.73 and an ultimate completion date of September 29, 2029, for i-STAT blood analyzers and related supplies. The BPA was established through full and open competition following a solicitation posted August 28, 2024, for point-of-care blood analyzers, reagents, and consumables to support clinical testing at VA Long Beach Healthcare System. The...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded Abbott Laboratories Inc. a blanket purchase agreement call contract to provide glucose test strips and meters in support of veterans healthcare programs. The contract utilizes the General Services Administration Schedule 65-VII for Invitro Diagnostics, Reagents, and Tests, and has a potential value of $283,125. No set-aside provision was applied. Performance will occur at multiple...
- The Department of Veterans Affairs (VA) has awarded a Blanket Purchase Agreement (BPA) under the Federal Supply Schedule (FSS) contract V797P-7322A to Abbott Laboratories Inc., a large pharmaceutical and medical device manufacturer. This single-award BPA, valued at $177,780.31, will enable the VA's Veterans Integrated Service Network 2 (VISN 2) to procure Abbott's i-STAT Troponin Multipurpose Point of Care Testing equipment, supplies, and related services on a cost-per-test basis. The contract...
- 36C24826A0022Blanket Purchase Agreement
- 1Federal Contract Awards
Veterans Integrated Service Network 8 awarded a Blanket Purchase Agreement to Abbott Laboratories Inc. on July 1, 2026, with a ceiling of $2,764,266.11 and an ultimate completion date of June 30, 2031, for whole blood glucose monitoring equipment and services. The BPA covers point-of-care whole blood glucose meters and analyzers for inpatient bedside and outpatient clinic locations across seven VISN 8 facilities in Florida and Puerto Rico: Bay Pines VA Healthcare System, Miami VA Healthcare System, West Palm Beach Healthcare System, North Florida/South Georgia VA Healthcare System, VA Caribbean Healthcare System (San Juan, Puerto Rico), James A. Haley Veterans' Hospital and Clinics (Tampa, Florida), and Orlando VA Healthcare System. Additional VISN 8 facilities may be added through supplemental agreement. The contractor shall provide all equipment, reagents, standards, controls, supplies, parts, accessories, service maintenance, network support, training, installation, and shipping necessary for whole blood glucose cost-per-test services. Work must comply with Federal, State, and local ordinances, FDA guidelines, and manufacturer specifications. NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) applies. A BPA call for whole blood glucose monitoring was issued on July 1, 2026, with a ceiling of $102,140.36 and an ultimate completion date of September 30, 2026, on a firm fixed price basis, with performance at North Chicago, Illinois.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 6/30/26 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call 36C24826A0022-36C24826N0676 | Abbott Laboratories Inc. | $102.1k | 7/1/26 | 9/30/26 | 6/30/26 |
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6650--VISN 8 Whole Blood Glucose Monitoring | 36C24826Q0671 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 | Pre-Solicitation 1/3 | 5/7/26, 10:19 AM | |
6650--VISN 8 Whole Blood Glucose Monitoring | 36C24826Q0671 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 | Solicitation 2/3 | 5/7/26, 12:17 PM | |
6650--VISN 8 Whole Blood Glucose Monitoring | 36C24826Q0671 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 | Award Notice 3/3 | 7/1/26, 5:18 PM |